S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
CGC   14.22 (-7.24%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
T   39.63 (+0.33%)
ACB   2.28 (-16.48%)
PRI   131.10 (+0.37%)
BAC   32.96 (+0.09%)
DIS   147.65 (+2.06%)
S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
CGC   14.22 (-7.24%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
T   39.63 (+0.33%)
ACB   2.28 (-16.48%)
PRI   131.10 (+0.37%)
BAC   32.96 (+0.09%)
DIS   147.65 (+2.06%)
S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
CGC   14.22 (-7.24%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
T   39.63 (+0.33%)
ACB   2.28 (-16.48%)
PRI   131.10 (+0.37%)
BAC   32.96 (+0.09%)
DIS   147.65 (+2.06%)
S&P 500   3,122.03 (+0.05%)
DOW   28,036.22 (+0.11%)
QQQ   203.07 (+0.08%)
CGC   14.22 (-7.24%)
BABA   184.61 (-0.47%)
GE   11.44 (-0.69%)
T   39.63 (+0.33%)
ACB   2.28 (-16.48%)
PRI   131.10 (+0.37%)
BAC   32.96 (+0.09%)
DIS   147.65 (+2.06%)
Log in

Ligand Pharmaceuticals Earnings Date, Estimates & History (NASDAQ:LGND)

$103.52
-4.27 (-3.96 %)
(As of 11/18/2019 04:00 PM ET)
Today's Range
$102.68
Now: $103.52
$107.79
50-Day Range
$95.73
MA: $106.10
$113.65
52-Week Range
$84.45
Now: $103.52
$166.52
Volume33,968 shs
Average Volume356,851 shs
Market Capitalization$1.82 billion
P/E Ratio16.48
Dividend YieldN/A
Beta1.26

Earnings

Ligand Pharmaceuticals (NASDAQ:LGND) Earnings Information

Ligand Pharmaceuticals last announced its quarterly earnings results on November 5th, 2019. The biotechnology company reported $0.49 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.61 by $0.12. The company had revenue of $24.81 million for the quarter, compared to analysts' expectations of $22.49 million. Its revenue for the quarter was down 45.7% on a year-over-year basis. Ligand Pharmaceuticals has generated $6.28 earnings per share over the last year and currently has a price-to-earnings ratio of 16.5. Ligand Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2020 based off prior year's report dates.

Ligand Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Ligand Pharmaceuticals (NASDAQ:LGND) Earnings Estimates

Current Year EPS Consensus Estimate: $2.08 EPS
Next Year EPS Consensus Estimate: $2.94 EPS

Ligand Pharmaceuticals (NASDAQ LGND) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/6/2020
(Estimated)
       
11/5/2019Q3 2019$0.61$0.49$1.11$22.49 million$24.81 millionTranscript
7/30/2019Q2$0.38$0.68$1.56$21.01 million$24.99 millionListen
5/2/20193/31/2019$0.88$1.16($29.38)$38.28 million$43.48 millionTranscript
2/7/201912/31/2018$1.22$1.70$4.88$52.58 million$59.59 millionN/A
11/8/20189/30/2018$1.03$1.32($0.10)$41.99 million$45.66 millionListen
8/6/2018Q2 2018$2.34$2.59$1.79$82.20 million$90.00 millionN/A
5/8/2018Q1 2018$1.29$1.55$0.93$43.02 million$56.16 millionN/A
2/21/2018Q4 2017$1.19$1.31$2.39$49.39 million$50.50 millionTranscript
11/9/2017Q3 2017$0.37$0.69$0.74$31.04 million$33.38 millionN/A
8/7/2017Q2 2017$0.25$0.67$0.82$24.40 million$28.00 millionListen
5/9/2017Q1 2017$0.55$0.39$0.56$30.25 million$29.27 millionListen
2/23/2017Q416$1.19($0.15)($0.15)$40.34 million$38.20 millionN/A
11/3/2016Q316$0.59$0.62$0.03$23.64 million$21.62 millionN/A
8/4/2016Q216$0.40$0.50$0.62$18.12 million$19.50 millionN/A
5/4/2016Q116$0.67$0.97$1.24$26.45 million$29.60 millionN/A
2/10/2016Q415$0.51$0.66$0.75$24.71 million$21.20 millionListen
11/9/2015Q315$0.42$0.56($9.62)$17.80 million$17.70 millionN/A
8/4/2015Q215$0.40$1.63$2.15$17.00 million$18.42 millionN/A
5/11/2015Q115$0.12$0.33$0.36$13.50 million$14.60 millionListen
2/9/2015Q414$0.48$0.48$0.62$23.88 million$23.00 millionN/A
10/27/2014Q314$0.21$0.19$0.32$14.60 million$15.00 millionListen
8/4/2014Q214$0.14$0.24$0.13$9.73 million$10.60 millionTranscript
5/7/2014Q114$0.25$0.35$0.40$13.63 million$16.00 millionTranscript
2/11/2014Q4 2013$0.20$0.29$0.49$13.72 million$14.70 millionN/A
10/30/2013Q3 2013$0.06$0.12$0.15$10.81 million$13.00 millionListen
8/1/2013Q2 2013$0.05$0.07($0.16)$9.48 million$9.58 millionN/A
5/8/2013Q1 2013$0.12$0.15$0.23$10.00 million$11.70 millionN/A
2/13/2013Q4 2012$0.19$12.90 million$13.60 millionTranscript
11/5/2012Q312$0.04($0.01)$8.40 million$6.40 millionN/A
8/8/2012Q2 2012($0.03)($0.20)($0.29)N/A
5/2/2012Q1 2012$0.02($0.02)($0.11)N/A
2/7/2012Q4 2011$0.02$0.24$0.24N/A
11/8/2011Q3 2011($0.20)($0.20)N/A
8/8/2011Q2 2011$0.01($0.05)($0.05)N/A
5/10/2011Q1 2011$0.04($0.06)($0.60)N/A
2/15/2011Q4 2010$0.02$0.24$0.36N/A
11/9/2010Q3 2010($3.62)($3.62)N/A
8/5/2010Q2 2010$0.06($0.01)($0.01)N/A
5/5/2010Q1 2010($0.18)($0.15)($0.16)N/A
2/9/2010Q4 2009$0.07($0.04)N/A
11/5/2009Q3 2009($0.30)($0.18)($0.46)N/A
8/3/2009Q2 2009($0.42)($0.22)($0.35)N/A
5/6/2009Q1 2009($0.24)($0.29)($0.42)N/A
2/12/2009Q4 2008($0.36)($0.11)$4.09N/A
7/31/2008Q2 2008($0.42)($0.31)($0.21)N/A
5/1/2008Q1 2008($0.12)($0.61)($0.97)N/A
2/20/2008Q4 2007$0.24($0.34)($1.05)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 11/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel